Company intelligence / Profile preview

Opticarma India

Ahmedabad, Gujarat, India

Ownership: Private
Development stage: Other

Overview

Opticarma India is a specialty pharmaceutical company based in Ahmedabad, India, primarily dedicated to the field of ophthalmology. The company focuses on developing and marketing a diverse range of eye care products, including treatments for glaucoma, ocular hypertension, and allergic conjunctivitis. By utilizing strategic manufacturing partnerships and maintaining high quality standards, Opticarma aims to deliver affordable and effective therapeutic solutions to patients globally. Their portfolio includes widely recognized small molecule generics such as Latanoprost, Brimonidine, and Moxifloxacin.

Therapeutic areas: ImmunologyOphthalmologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Opticarma India.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opticarma India.

Explore the full profile